Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AdvaMed: Medtech Industry Wants Seat At Biden’s Coronavirus Response Table

Executive Summary

The largest medical device lobby group in the US says it’s open to the administration’s decision to invoke the Defense Production Act to boost testing and PPE production, but wants to be consulted on how to implement it.

You may also be interested in...



Health Care Leaders Propose Framework To Better Prepare For The Next Pandemic

A report from prominent health care industry leaders proposes actions the federal government and industry can take to avoid product shortages and regulatory hurdles in the next public health emergency.

QUOTED. 27 January 2021. Scott Whitaker.

Trade group AdvaMed should be consulted on how to implement the Defense Production Act to boost testing and PPE production, CEO Scott Whitaker said in a letter to President Biden.

Industry Lobby Group Supports Use Of DPA To Ramp Up PPE Production

In a letter to US Vice President Mike Pence, AdvaMed says it supports the federal government using its broad legal authority under the Defense Production Act to mandate increased production of personal protective equipment for outpatient physicians and health care workers. However, it cautioned the government should use the law to facilitate production rather than to take over medtech manufacturing firms.

Related Content

Topics

UsernamePublicRestriction

Register

OM007466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel